These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11237076)

  • 1. Mild cognitive impairment in the elderly.
    Brandt J
    Am Fam Physician; 2001 Feb; 63(4):620, 622, 625-6. PubMed ID: 11237076
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
    den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
    Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mild cognitive impairment].
    Nakano N; Hatakeyama Y; Yoshida T
    Ryoikibetsu Shokogun Shirizu; 2003; (40):193-6. PubMed ID: 14626099
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
    Borroni B; Di Luca M; Padovani A
    Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mild cognitive impairment as early symptom of mental degeneration. Is there no preventative dementia treatment? (interview by Judith Neumaier)].
    Gutzmann H
    MMW Fortschr Med; 2004 Mar; 146(13):59. PubMed ID: 15219136
    [No Abstract]   [Full Text] [Related]  

  • 7. Current and future treatments for cognitive deficits in dementia.
    McLendon BM; Chen GG; Doraiswamy PM
    Curr Psychiatry Rep; 2000 Feb; 2(1):20-3. PubMed ID: 11122927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.
    Hussain H
    Neurology; 2007 Jul; 69(4):409. PubMed ID: 17646640
    [No Abstract]   [Full Text] [Related]  

  • 9. New tools for taking control of Alzheimer disease.
    Johns Hopkins Med Lett Health After 50; 2001 Dec; 13(10):4-5. PubMed ID: 11727444
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer's disease: a progress report. How far the search for treatments has come and where it is heading.
    Harv Ment Health Lett; 2003 Nov; 20(5):1-4. PubMed ID: 14633486
    [No Abstract]   [Full Text] [Related]  

  • 11. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for the treatment of dementias].
    Trabucchi M; Bianchetti A
    Recenti Prog Med; 2000 Sep; 91(9):444-9. PubMed ID: 11021167
    [No Abstract]   [Full Text] [Related]  

  • 14. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophy accelerates with conversion from mild cognitive impairment to Alzheimer disease.
    Mueller SG; Dickerson BC
    Neurology; 2008 May; 70(19 Pt 2):1728-9. PubMed ID: 18458214
    [No Abstract]   [Full Text] [Related]  

  • 16. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in dementia: correlations with atrophy and cerebrovascular disease quantified by magnetic resonance imaging.
    Swartz RH; Black SE; Sela G; Bronskill MJ
    Brain Cogn; 2002 Jul; 49(2):228-32. PubMed ID: 15259397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
    Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.
    deToledo-Morrell L; Stoub TR; Bulgakova M; Wilson RS; Bennett DA; Leurgans S; Wuu J; Turner DA
    Neurobiol Aging; 2004 Oct; 25(9):1197-203. PubMed ID: 15312965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.